{"protocolSection":{"identificationModule":{"nctId":"NCT03991364","orgStudyIdInfo":{"id":"NRC-2019-01-002"},"organization":{"fullName":"National Rehabilitation Center, Seoul, Korea","class":"OTHER_GOV"},"briefTitle":"Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke","officialTitle":"Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke"},"statusModule":{"statusVerifiedDate":"2019-06","overallStatus":"UNKNOWN","lastKnownStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-07-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2020-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2020-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-06-18","studyFirstSubmitQcDate":"2019-06-18","studyFirstPostDateStruct":{"date":"2019-06-19","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-06-18","lastUpdatePostDateStruct":{"date":"2019-06-19","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Joon-Ho Shin","investigatorTitle":"Team manager","investigatorAffiliation":"National Rehabilitation Center, Seoul, Korea"},"leadSponsor":{"name":"National Rehabilitation Center, Seoul, Korea","class":"OTHER_GOV"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Comparison of the experimental group that applied the speed of the robot-assisted gait training constantly and the control group that applied the gradual increase of the speed of the robot-assisted gait training."},"conditionsModule":{"conditions":["Stroke"],"keywords":["Robot-assisted gait training","stroke","gait speed"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"SINGLE","whoMasked":["PARTICIPANT"]}},"enrollmentInfo":{"count":20,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Constant gait speed group","type":"EXPERIMENTAL","description":"experimental group that applied the speed of the robot-assisted gait training constantly","interventionNames":["Other: Constant gait speed group"]},{"label":"Increasing gait speed group","type":"OTHER","description":"control group that applied the gradual increase of the speed of the robot-assisted gait training","interventionNames":["Other: Increasing gait speed group"]}],"interventions":[{"type":"OTHER","name":"Constant gait speed group","description":"The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.","armGroupLabels":["Constant gait speed group"]},{"type":"OTHER","name":"Increasing gait speed group","description":"The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.","armGroupLabels":["Increasing gait speed group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Energy expenditure (EE)","description":"EE(kcal/min): energy expenditure per minute","timeFrame":"2 weeks after baseline"}],"secondaryOutcomes":[{"measure":"Energy expenditure (EE)","description":"EE(kcal/min): energy expenditure per minute","timeFrame":"baseline, 1 weeks after baseline, 3 weeks after baseline"},{"measure":"Heart rate (HR)","description":"Cardiac frequency","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"Volume of Oxygen (VO2)","description":"O2 consumption/1min","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"Respiratory Quotient (R)","description":"Respiratory quotient","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"Metabolic equivalent (METS)","description":"the amount of oxygen consumed while sitting at rest and is equal to 3.5 ml O2 per kg body weight x min","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"oxygenated hemoglobin (OxyHb)","description":"oxygenated hemoglobin concentration of cortical activation","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"deoxygenated hemoglobin (DeoxyHb)","description":"deoxygenated hemoglobin concentration of cortical activation","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"Lower extremity Fugl-Meyer Assessment","description":"Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"Functional Ambulation Category","description":"Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"10m walk test","description":"10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"},{"measure":"timed up and go test","description":"simple test used to assess a person's mobility and requires both static and dynamic balance","timeFrame":"baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Hemiplegic patients secondary to first cerebrovascular accidents\n* Functional ambulation category score â‰¥ 3\n\nExclusion Criteria:\n\n* History of surgery of affected lower limb\n* Fracture of affected lower limb","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Joon-Ho Shin, MS","role":"CONTACT","phone":"82-2-901-1884","email":"asfreelyas@gmail.com"}],"overallOfficials":[{"name":"Joon-Ho Shin, MS","affiliation":"National Rehabilitation Center","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"National Rehabilitation Center","city":"Seoul","zip":"142884","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"}]},"interventionBrowseModule":{"meshes":[{"id":"D000008694","term":"Methamphetamine"}],"ancestors":[{"id":"D000000697","term":"Central Nervous System Stimulants"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000013566","term":"Sympathomimetics"},{"id":"D000001337","term":"Autonomic Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000015259","term":"Dopamine Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000018663","term":"Adrenergic Agents"},{"id":"D000018759","term":"Adrenergic Uptake Inhibitors"},{"id":"D000014179","term":"Neurotransmitter Uptake Inhibitors"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000018765","term":"Dopamine Uptake Inhibitors"}],"browseLeaves":[{"id":"M11364","name":"Methamphetamine","asFound":"Skills training","relevance":"HIGH"},{"id":"M3719","name":"Central Nervous System Stimulants","relevance":"LOW"},{"id":"M16035","name":"Sympathomimetics","relevance":"LOW"},{"id":"M7163","name":"Dopamine","relevance":"LOW"},{"id":"M17652","name":"Dopamine Agents","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"},{"id":"M20436","name":"Adrenergic Agents","relevance":"LOW"},{"id":"M20522","name":"Dopamine Uptake Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"CNSSti","name":"Central Nervous System Stimulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"CaAg","name":"Cardiotonic Agents"}]}},"hasResults":false}